Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/9/2025

Combination Therapy for Depression with Mirtazapine and Trazodone

Guideline Support and Rationale

  • The American Academy of Sleep Medicine guidelines support combining sedating antidepressants, noting the general safety and efficacy of this combination, which applies to combining mirtazapine and trazodone for depression management 1
  • The recommended treatment sequence for depression with insomnia includes combining a sedating antidepressant, such as trazodone and mirtazapine, as a legitimate strategy 2, 3
  • The combination of mirtazapine and trazodone can target multiple neurotransmitter systems simultaneously, potentially improving efficacy while using lower doses of each agent 1

Clinical Advantages and Monitoring Considerations

  • Mirtazapine has a faster onset of action than many SSRIs and is effective for patients with depression accompanied by insomnia, anorexia, or weight loss 4
  • Excessive sedation is the primary concern when combining two sedating antidepressants, and monitoring daytime drowsiness is crucial, especially in the first 1-2 weeks 1, 4
  • Weight gain and increased appetite occur more frequently with mirtazapine and should be discussed with patients upfront 4

Dosing Strategy and Common Pitfalls

  • Start mirtazapine at 15 mg at bedtime while continuing trazodone at its current dose, and assess therapeutic response within 1-2 weeks 4
  • Allow 6-8 weeks before concluding inadequate response, and don't assume failure too early 4
  • Don't neglect to counsel patients about expected weight gain with mirtazapine, and monitor for rare but serious cardiovascular effects with trazodone 4

Follow-up and Treatment Duration

  • Follow up within 1-2 weeks after adding mirtazapine to assess tolerability and early response, and continue successful treatment for 4-9 months after achieving remission in first-episode depression 4
  • If inadequate response by 6-8 weeks, consider switching strategies rather than continuing ineffective treatment 4

REFERENCES

1

clinical guideline for the evaluation and management of chronic insomnia in adults. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

2

clinical guideline for the evaluation and management of chronic insomnia in adults. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

3

clinical guideline for the evaluation and management of chronic insomnia in adults. [LINK]

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2008

4

Mirtazapine Treatment Guidelines for Major Depressive Disorder [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026